At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ADC Agree
Market Closed 04-11 16:00:00 EDT
74.91
+1.96
+2.69%
盘后75.38
+0.47+0.63%
19:51 EDT
High75.41Low72.39Vol1.77M
Open73.13D1 Closing72.95Amplitude4.13%
Mkt Cap8.02BTradable Cap7.86BTotal Shares107.03M
T/O131.62MT/O Rate1.68%Tradable Shares104.98M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
Loading ...
JX Energy, Lender Agree on Repayment Options for $1.5 Million Loan
MT Newswires Live  ·  04-11 12:48
JX Energy, Lender Agree on Repayment Options for $1.5 Million Loan
Most Shareholders Will Probably Agree With Bank of Tianjin Co., Ltd.'s (HKG:1578) CEO Compensation
Simply Wall St.  ·  04-10 22:45
Most Shareholders Will Probably Agree With Bank of Tianjin Co., Ltd.'s (HKG:1578) CEO Compensation
BRIEF-Agree Realty Declares Increased Monthly Common Dividend
Reuters  ·  04-10 20:49
BRIEF-Agree Realty Declares Increased Monthly Common Dividend
Agree Realty Increases Monthly Dividend to $0.256 Per Share, Payable May 14 to Holders of Record April 30
MT Newswires Live  ·  04-10 20:12
Agree Realty Increases Monthly Dividend to $0.256 Per Share, Payable May 14 to Holders of Record April 30
Agree Realty increases monthly common dividend 1.2% to 25.6c per share
TIPRANKS  ·  04-10 20:10
Agree Realty increases monthly common dividend 1.2% to 25.6c per share
Agree Realty Declares Increased Monthly Common Dividend
THOMSON REUTERS  ·  04-10 20:05
Agree Realty Declares Increased Monthly Common Dividend
Press Release: Agree Realty Declares Increased Monthly Common Dividend
Dow Jones  ·  04-10 20:05
Press Release: Agree Realty Declares Increased Monthly Common Dividend
OS Therapies Announces Positive Data for OST-HER2 in the Treatment of Unresected Osteosarcoma in Dogs Opening the Potential for Use as Front-Line Therapy in Humans
Business Wire  ·  04-10 11:42
OS Therapies Announces Positive Data for OST-HER2 in the Treatment of Unresected Osteosarcoma in Dogs Opening the Potential for Use as Front-Line Therapy in Humans
OS Therapies Completes Acquisition of Advaxis Immunotherapies Clinical, Pre-clinical and IP Assets from Ayala Pharmaceuticals
Business Wire  ·  04-09
OS Therapies Completes Acquisition of Advaxis Immunotherapies Clinical, Pre-clinical and IP Assets from Ayala Pharmaceuticals
Trump Says South Korea, Others, Are Ready to Agree Trade Deals -- WSJ
Dow Jones  ·  04-08
Trump Says South Korea, Others, Are Ready to Agree Trade Deals -- WSJ
Agree Realty (ADC) Receives a Buy from Evercore ISI
TIPRANKS  ·  04-08
Agree Realty (ADC) Receives a Buy from Evercore ISI
PDS Biotech Announces PDS01ADC Clinical Data to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025
GlobeNewswire  ·  04-08
PDS Biotech Announces PDS01ADC Clinical Data to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025
Bluejay Diagnostics Plunges Premarket After Investors Agree to Exercise Warrants at Reduced Price
MT Newswires Live  ·  04-08
Bluejay Diagnostics Plunges Premarket After Investors Agree to Exercise Warrants at Reduced Price
Eutelsat and Panasonic Avionics Agree Multi-Year Extension of Capacity Agreement on EUTELSAT 10B
Business Wire  ·  04-08
Eutelsat and Panasonic Avionics Agree Multi-Year Extension of Capacity Agreement on EUTELSAT 10B
Press Release: TuHURA Biosciences, Inc. Appoints Dr. Bertrand Le Bourdonnec as Executive Vice President, Head of Drug Discovery, Early Development, and Program Management
Dow Jones  ·  04-07
Press Release: TuHURA Biosciences, Inc. Appoints Dr. Bertrand Le Bourdonnec as Executive Vice President, Head of Drug Discovery, Early Development, and Program Management
ALX Oncology Receives IND Clearance from U.S. FDA for ALX2004, a Novel EGFR-targeted Antibody-drug Conjugate
GlobeNewswire  ·  04-07
ALX Oncology Receives IND Clearance from U.S. FDA for ALX2004, a Novel EGFR-targeted Antibody-drug Conjugate
OS Therapies Requests Meeting with FDA to Gain Agreement on Surrogate Endpoint(s) for Breakthrough Therapy Designation & Accelerated Approval of OST-HER2 in the Prevention of Recurrence of Fully Resected, Lung Metastatic Osteosarcoma
Business Wire  ·  04-07
OS Therapies Requests Meeting with FDA to Gain Agreement on Surrogate Endpoint(s) for Breakthrough Therapy Designation & Accelerated Approval of OST-HER2 in the Prevention of Recurrence of Fully Resected, Lung Metastatic Osteosarcoma
RBC Capital Keeps Their Buy Rating on ADC Therapeutics (ADCT)
TIPRANKS  ·  04-05
RBC Capital Keeps Their Buy Rating on ADC Therapeutics (ADCT)
ENHERTU® Approved in the EU as First HER2 Directed Therapy for Patients with HR Positive, HER2 Low or HER2 Ultralow Metastatic Breast Cancer Following at Least One Endocrine Therapy
Business Wire  ·  04-04
ENHERTU® Approved in the EU as First HER2 Directed Therapy for Patients with HR Positive, HER2 Low or HER2 Ultralow Metastatic Breast Cancer Following at Least One Endocrine Therapy
Agree Realty Is Maintained at Neutral by Mizuho
Dow Jones  ·  04-03
Agree Realty Is Maintained at Neutral by Mizuho

Introduction

Company Name.
Agree
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Agree Realty Corporation (the “Company”), a Maryland corporation, is a fully integrated real estate investment trust (“REIT”) primarily focused on the ownership, acquisition, development and management of retail properties net leased to industry leading tenants. The Company was founded in 1971 by its current Executive Chairman, Richard Agree, and its common stock was listed on the New York Stock Exchange in 1994. As of March 31, 2024, the Company owned 2,161 properties, with a total gross leasable area (“GLA”) of approximately 44.9 million square feet.
Issue price:
--
Invest in Global Markets with Tiger Brokers!
Open App